Funded startups/Pulmatrix, Inc.

Pulmatrix, Inc.

SEC filing

Biotechnology · Framingham, MA

Form D on EDGAR

Amount raised$1Msold at filing

Total offering$1M

Investors in the raise1count reported to the SEC

FiledApr 15, 2026first sale Mar 26, 2026

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Anand VaradanDirector

Richard BatyckyDirector

Michael HigginsDirector

Peter LudlumExecutive Officer

Christopher CabellDirector

Todd BazemoreDirector

Executive officers, directors and promoters as listed on the Form D.